Response to IL‐17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein‐coding and untranslated regions of the IL‐17A gene: results from a multicentre study of four European psoriasis cohorts
暂无分享,去创建一个
M. Coenen | J. Lambert | M. Hakobjan | E. D. De Jong | K. Kingo | M. Talamonti | M. Galluzzo | J. M. Van den Reek | J. Reek | M. Coenen | T. Traks | L. V. van Vugt | E. Meulewaeter | N. Heddes | Madeke J. H. Coenen | Jo Lambert | L. J. Vugt | Marina Hakobjan | Mark S. Talamonti | E.M.G.J. de Jong